Announced Sat, 4 Jul · 18:06 IST
Board shake-up: new MD and CFO, authorised capital raised to Rs 100 Cr
Corporate Actions View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Sarda Proteins board approved raising authorised equity capital from Rs 13 Cr to Rs 100 Cr (shares of Rs 10 each). Chirag Thumar resigned as MD; Shirish Savaliya appointed new MD for 5 years. Yagnik Satasiya moved from CFO to Chairperson. Drashti Delvadiya named new CFO. Three directors also resigned. EGM called for shareholder approvals.
Likely market impact
Major leadership overhaul. Sharp jump in authorised capital hints at possible fundraising, expansion, or stock split plans ahead.